Switching for convenience from first-line injectable treatments to oral treatments in multiple sclerosis: data from a retrospective cohort study - Université de Lille
Article Dans Une Revue Multiple Sclerosis and Related Disorders Année : 2019

Switching for convenience from first-line injectable treatments to oral treatments in multiple sclerosis: data from a retrospective cohort study

Fichier non déposé

Dates et versions

hal-04516284 , version 1 (22-03-2024)

Identifiants

Citer

Geraldine Buard, Jonathan Giovannelli, Olivier Outteryck, Nawal Hadhoum, Julien Lannoy, et al.. Switching for convenience from first-line injectable treatments to oral treatments in multiple sclerosis: data from a retrospective cohort study. Multiple Sclerosis and Related Disorders, 2019, Multiple Sclerosis and Related Disorders, 33, pp.39-43. ⟨10.1016/j.msard.2019.05.015⟩. ⟨hal-04516284⟩

Collections

RIIP UNIV-LILLE
0 Consultations
0 Téléchargements

Altmetric

Partager

More